Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Liam C Woerner

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Expert Review of Anticancer Therapy|October 16, 2024
Future investigative directions for novel therapeutic targets in head and neck cancerJacqueline P Nguyen, Liam C Woerner, Daniel E Johnson, et al.
Biorxiv : the Preprint Server for Biology|October 1, 2025
Human Papilloma Virus does not fully inactivate p53 cellular activity in HNSCCJovanka Gencel-Augusto, Hua Li, Liam C Woerner, et al.
Head & Neck|October 31, 2025
Human Papilloma Virus Does Not Fully Inactivate p53 Cellular Activity in HNSCCJovanka Gencel-Augusto, Hua Li, Liam C Woerner, et al.
Biochemical and Biophysical Research Communications|March 28, 2025
Neddylation as a target in PIK3CA-mutated head and neck cancerShorook Naara, Zhibin Cui, Adila Izgutdina, et al.
Molecular Cancer Therapeutics|February 20, 2025
Blockade of the PGE2 Pathway Inhibits the Growth of PTEN-Deficient HNSCC TumorsJacqueline P Nguyen, Shorook Na'ara, Liam C Woerner, et al.
Cancer Cell|August 29, 2025
Safety and efficacy of a STAT3-targeted cyclic oligonucleotide: From murine models to a phase 1 clinical trial in pet cats with oral cancerJennifer R Grandis, Katherine A Skorupski, Ning Cheng, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Expert Review of Anticancer Therapy|October 16, 2024
Future investigative directions for novel therapeutic targets in head and neck cancerJacqueline P Nguyen, Liam C Woerner, Daniel E Johnson, et al.
Biorxiv : the Preprint Server for Biology|October 1, 2025
Human Papilloma Virus does not fully inactivate p53 cellular activity in HNSCCJovanka Gencel-Augusto, Hua Li, Liam C Woerner, et al.
Head & Neck|October 31, 2025
Human Papilloma Virus Does Not Fully Inactivate p53 Cellular Activity in HNSCCJovanka Gencel-Augusto, Hua Li, Liam C Woerner, et al.
Biochemical and Biophysical Research Communications|March 28, 2025
Neddylation as a target in PIK3CA-mutated head and neck cancerShorook Naara, Zhibin Cui, Adila Izgutdina, et al.
Molecular Cancer Therapeutics|February 20, 2025
Blockade of the PGE2 Pathway Inhibits the Growth of PTEN-Deficient HNSCC TumorsJacqueline P Nguyen, Shorook Na'ara, Liam C Woerner, et al.
Cancer Cell|August 29, 2025
Safety and efficacy of a STAT3-targeted cyclic oligonucleotide: From murine models to a phase 1 clinical trial in pet cats with oral cancerJennifer R Grandis, Katherine A Skorupski, Ning Cheng, et al.
Pageof 1